PYC Therapeutics Limited

OTCPK:PYCX.F Stock Report

Market Cap: US$1.1b

PYC Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:PYCX.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Jun 26BuyUS$45,047,601The Retail Employees Superannuation TrustCompany49,500,193US$0.91
24 Mar 26BuyUS$69,640Rohan HockingsIndividual82,550US$0.84
06 Mar 26BuyUS$84,209Rohan HockingsIndividual80,010US$1.05
06 Mar 26BuyUS$129,455Ian ConstableIndividual123,000US$1.05
20 Feb 26BuyUS$55,894,258Firetrail Investments Pty LtdCompany53,082,328US$1.05
11 Feb 26BuyUS$89,525,890RA Capital Management, L.P.Company83,850,000US$1.07
26 Nov 25BuyUS$130,303Rohan HockingsIndividual133,350US$0.98
19 Nov 25BuyUS$6,078,235Mccusker Holdings Pty. Ltd.Company7,327,200US$0.88
05 Nov 25BuyUS$6,656,121Firetrail Investments Pty LtdCompany8,450,533US$0.79
05 Nov 25SellUS$1,083,764Firetrail Investments Pty LtdCompany1,364,743US$0.79

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PYCX.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies46,517,9294.73%
VC/PE Firms83,850,0008.53%
Institutions114,041,60411.6%
Individual Insiders223,877,54722.8%
General Public515,223,36752.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 68.6%.

Top Shareholders

Top 23 shareholders own 47.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19%
Alan Tribe
186,726,741US$201.6m0%no data
8.53%
RA Capital Management, L.P.
83,850,000US$90.5m0%0.92%
5.03%
The Retail Employees Superannuation Trust
49,500,193US$53.5m0%5.72%
3.61%
Firetrail Investments Pty Ltd
35,534,882US$38.4m20.5%3.09%
2.78%
Mccusker Holdings Pty. Ltd.
27,363,600US$29.5m0%no data
1.72%
David Sietsma
16,875,000US$18.2m0%no data
1.05%
Wilson Asset Management (International) Pty Ltd.
10,309,283US$11.1m0%0.34%
0.92%
Datamatch Pty Ltd
9,000,000US$9.7m0%no data
0.86%
Andbank Asset Management Luxembourg SA
8,495,932US$9.2m0%6.53%
0.84%
Adrian Bonaddio
8,249,561US$8.9m0%no data
0.65%
John Baird
6,400,266US$6.9m0%no data
0.54%
Masali Pty. Ltd.
5,334,329US$5.8m0%no data
0.51%
Adam Bonaddio
5,002,069US$5.4m0%no data
0.49%
Selwood Barton Pty Ltd
4,820,000US$5.2m0%no data
0.43%
McCusker Charitable Foundation
4,200,000US$4.5m0%71.48%
0.33%
Fidelity International Ltd
3,287,691US$3.6m0%no data
0.22%
BlackRock, Inc.
2,197,076US$2.4m0%no data
0.033%
Ian Constable
328,000US$354.2k60%no data
0.03%
Rohan Hockings
295,910US$319.6k122%no data
0.029%
Manulife Asset Management
285,885US$308.7k0%no data
0.012%
KLP Kapitalforvaltning AS
117,012US$126.4k0%no data
0.0058%
Dimensional Fund Advisors LP
57,259US$61.8k0%no data
0.0057%
State Street Global Advisors, Inc.
56,391US$60.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 22:24
End of Day Share Price 2026/06/29 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PYC Therapeutics Limited is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Melissa BensonBarrenjoey Markets Pty Limited
Thomas WakimBell Potter
David MartinBloom Burton & Co.